首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >A Randomized Controlled Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes

【2h】

A Randomized Controlled Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes

机译：一项随机对照按靶点研究评估2型糖尿病患者使用设备支持或常规滴定管理的300 G / g甘精胰岛素（Gla-300）的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The efficacy/safety of device-supported versus routine titration with Gla-300 in type 2 diabetes (T2DM) was evaluated.

机译：评估了在2型糖尿病（T2DM）中使用设备支持的Gla-300进行常规滴定的安全性/安全性。

著录项

期刊名称 Journal of Diabetes Science and Technology
作者
Melanie Davies; Steve Bain; Guillaume Charpentier; Frank Flacke; Harmonie Goyeau; Michael Woloschak; Christoph Hasslacher; Giacomo Vespasiani; Steven Edelman;
展开▼
作者单位

展开▼
年(卷),期 2019(13),5
年度 2019
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类基础医学;
关键词
basal insulin; blood glucose meter; hypoglycemia; titration;

机译：基础胰岛素;血糖仪;低血糖;滴定;

相似文献

外文文献
中文文献

1. A Randomized Controlled, Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes [J] . Melanie Davies, Steve Bain, Guillaume Charpentier, Journal of Diabetes Science and Technology . 2019,第5期

机译：一项随机对照，按靶点研究评估2型糖尿病患者使用设备支持或常规滴定管理的300 G / g甘精胰岛素（Gla-300）的疗效和安全性
2. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6-17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial [J] . Diabetes care . 2020,第7期

机译：胰岛素龟甲300单位/ ml（GLA-300）的疗效和安全性与胰岛素和青少年（6-17岁）的胰岛素龟甲100个单位/ ml（GLA-100）（6-17岁）：Edition Junior随机对照试验的结果
3. Take Control: A randomized trial evaluating the efficacy and safety of self- versus physician-managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes [J] . Russell-Jones David, Dauchy Arnaud, Delgado Elias, Diabetes, obesity & metabolism . 2019,第7期

机译：采取控制：随机试验评估自我与医生管理胰岛素Marcance 300 U / ml在不受控制的2型糖尿病患者中的疗效和安全性
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. A randomized, open-label, intervention study to evaluate the effect of diet composition on weight gain in obese, type 2 diabetes patients receiving intensive insulin therapy. [D] . Villareal, Roland. 2008

机译：一项随机，开放标签，干预性研究，以评估饮食结构对接受强化胰岛素治疗的肥胖2型糖尿病患者体重增加的影响。
6. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial [O] . Thomas Danne, William V. Tamborlane, Oleg A. Malievsky, 2020

机译：1型糖尿病儿童和青少年（6至17岁）胰岛素甘草糖300单位/ mL（Gla-300）与胰岛素甘草碱100单位/ mL（Gla-100）的疗效和安全性：JUNIOR版的结果随机对照试验
7. Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial [O] . Thomas Danne, William V. Tamborlane, Oleg A. Malievsky, 2020

机译：胰岛素龟甲300单位/ ml（GLA-300）的疗效和安全性与胰岛素和青少年（6-17岁）的胰岛素龟甲100个单位/ ml（GLA-100）（6-17岁）：Edition Junior随机对照试验的结果

A Randomized Controlled Treat-to-Target Study Evaluating the Efficacy and Safety of Insulin Glargine 300 U/mL (Gla-300) Administered Using Either Device-Supported or Routine Titration in People With Type 2 Diabetes

摘要

著录项

相似文献

相关主题

期刊订阅